These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1571712)

  • 1. Epidermolysis bullosa acquisita, a rare late complication of allogeneic bone marrow transplantation?
    Burger J; Gmür J; Bruckner-Tuderman L
    Bone Marrow Transplant; 1992 Feb; 9(2):139-41. PubMed ID: 1571712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How do allogeneic bone marrow transplants cure leukaemia? The role of graft versus host disease.
    Powles R; Treleaven J; Millar J; Gordon-Smith EC; Tiley C; Findlay M; Teo C; Duncombe A; Robinson G
    Bone Marrow Transplant; 1991; 7 Suppl 2():9-10. PubMed ID: 1878737
    [No Abstract]   [Full Text] [Related]  

  • 3. [Gastroenterologic findings in graft versus host disease after allogenic bone marrow transplantation].
    Kreisel W; Fauser AA; Dölken G; Herbst EW
    Z Gastroenterol; 1991 Jun; 29(6):289-93. PubMed ID: 1926962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine.
    Mehta J; Powles R; Treleaven J; Horton C; Tait D; Meller S; Pinkerton CR; Middleton G; Eisen T; Singhal S
    Bone Marrow Transplant; 1996 Oct; 18(4):741-6. PubMed ID: 8899189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic versus autologous bone marrow transplantation versus chemotherapy for treatment of acute myeloid leukemia in first complete remission (BGM 84 and BGMT 87 studies). The BGMT Group.
    Reiffers J; Stoppa AM; Rigal-Huguet F; Michallet M; Marit G; Gastaut JA; Attal M; Corront B; Broustet A; Hollard D
    Bone Marrow Transplant; 1991; 7 Suppl 2():36. PubMed ID: 1878709
    [No Abstract]   [Full Text] [Related]  

  • 6. [Allogeneic skin transplantation in chronic graft-versus-host disease following bone marrow transplantation].
    Baumeister RG; Riel KA; Kolb HJ
    Chirurg; 1990 Jun; 61(6):438-40. PubMed ID: 2364784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
    Kröger N; Bornhäuser M; Ehninger G; Schwerdtfeger R; Biersack H; Sayer HG; Wandt H; Schäfer-Eckardt K; Beyer J; Kiehl M; Zander AR;
    Ann Hematol; 2003 Jun; 82(6):336-42. PubMed ID: 12728337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor leucocyte infusions after chemotherapy for patients relapsing with acute leukaemia following allogeneic BMT.
    Szer J; Grigg AP; Phillips GL; Sheridan WP
    Bone Marrow Transplant; 1993 Feb; 11(2):109-11. PubMed ID: 8435660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aggressive ulcerous stomatitis due to the herpes simplex virus in an allogeneic bone marrow transplant. A clinical case].
    Marinone MG; Paganelli C; Ferremi P; Rossi G; Izzi T
    Minerva Stomatol; 1991; 40(7-8):499-503. PubMed ID: 1753931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.
    Zander AR; Berger C; Kröger N; Stockshläder M; Krüger W; Horstmann M; Grimm J; Zeller W; Kabisch H; Erttmann R; Schönrock P; Kuse R; Braumann D; Illiger HJ; Fiedler W; de Witt M; Hossfeld KD; Weh HJ
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2671-5. PubMed ID: 10068272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Allogeneic bone marrow transplantation in acute myeloid leukemia (AML): results in 14 patients].
    Kos M; Hinterberger W; Gadner H; Haas O; Kalhs P; Panzer S; Geissler K; Schwarzinger I; Hinterberger-Fischer M; Neumann E
    Wien Klin Wochenschr; 1987 Apr; 99(7):217-22. PubMed ID: 3296468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
    Hambach L; Eder M; Dammann E; Battmer K; Stucki A; Heil G; Ganser A; Hertenstein B
    Bone Marrow Transplant; 2001 Oct; 28(7):705-7. PubMed ID: 11704795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune pancytopenia following allogeneic bone marrow transplantation.
    Klumpp TR; Caligiuri MA; Rabinowe SN; Soiffer RJ; Murray C; Ritz J
    Bone Marrow Transplant; 1990 Dec; 6(6):445-7. PubMed ID: 1965793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic bone marrow transplantation in children with acute myelogenous leukemia in first remission. Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP) and the Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO).
    Dini G; Boni L; Abla O; Uderzo C; Polchi P; Locatelli F; Di Bartolomeo P; Arcese W; Iori AP; Rossetti F
    Bone Marrow Transplant; 1994 Jun; 13(6):771-6. PubMed ID: 7920313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic marrow transplantation for acute non-lymphoblastic leukemia: first remission versus after first relapse.
    Buckner CD; Sanders J; Appelbaum FR
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():244-6. PubMed ID: 2653513
    [No Abstract]   [Full Text] [Related]  

  • 16. Autologous and allogeneic bone marrow transplantation for childhood acute nonlymphoblastic leukemia.
    Vowels M; Stevens M; Tiedemann K; Brown R
    Transplant Proc; 1992 Feb; 24(1):184-5. PubMed ID: 1539237
    [No Abstract]   [Full Text] [Related]  

  • 17. Unexplained effusions: association with allogeneic bone marrow transplantation and acute or chronic graft-versus-host disease.
    Pretnar J; Cernelc P; Mlakar U; Fortuna M
    Bone Marrow Transplant; 1996 Oct; 18(4):826. PubMed ID: 8899209
    [No Abstract]   [Full Text] [Related]  

  • 18. Severe acute graft-versus-host disease occurring after syngeneic BMT for AML in a patient not given prior cyclosporin A therapy.
    Hwang WY; Goh YT; Tan CH; How GF; Tan HC
    Bone Marrow Transplant; 2000 Jan; 25(2):205-7. PubMed ID: 10673682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants.
    Hallemeier C; Girgis M; Blum W; Brown R; Khoury H; Goodnough LT; Vij R; Devine S; Wehde M; Postma S; Lin HS; Dipersio J; Adkins D
    Biol Blood Marrow Transplant; 2004 May; 10(5):310-9. PubMed ID: 15111930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epidermolysa bullosa acquisita and graft-versus-host disease].
    Brassat S; Fleury J; Camus M; Monégier du Sorbier C; Guillet G
    Ann Dermatol Venereol; 2014 May; 141(5):369-73. PubMed ID: 24835650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.